CCND3

Across TCGA pan-cancer cohorts, CCND3 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CCND3 data layer compared with 22 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CCND3 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated CCND3 expression acts as an unfavorable survival marker.

LUAD and LSCC are the cancer types where CCND3 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Quartile	All	0.404	0.967	.017	4	view →
LSCC	DFS	Tertile	III,IV	0.406	0.894	.028	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CCND3–LUAD (OS)

Open the LUAD breakdown →